NCT06517069 Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients
| NCT ID | NCT06517069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yangzhou University |
| Condition | Visceral Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-05-01 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the effect and feasibility of percutaneous acupoint stimulation combined with oxycodone on postoperative visceral pain in laparoscopic patients, and provided a clinical basis for optimizing perioperative pain management in laparoscopic patients.
Eligibility Criteria
Inclusion Criteria: * Age 18-65 years * American Society of Anesthesiologists grade I-II * Body mass index (BMI) 18.5-30 kg/m2; * No ulceration or infection at the acupuncture stimulation site. Exclusion Criteria: * Allergic to the drugs used in the study; * People with unclear consciousness or cognitive dysfunction; * There are contraindications of percutaneous acupoint electrical stimulation; * Abnormal cardiopulmonary and liver and kidney function; * History of analgesic drug use within one week; * History of diabetes, myocardial infarction or cerebrovascular accident.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06517069 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Visceral Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06517069 currently recruiting?
Yes, NCT06517069 is actively recruiting participants. Contact the research team at myliu@yzu.edu for enrollment information.
Where is the NCT06517069 trial being conducted?
This trial is being conducted at Yangzhou, China.
Who is sponsoring the NCT06517069 clinical trial?
NCT06517069 is sponsored by Yangzhou University. The trial plans to enroll 120 participants.